Clinical trial

Cardiovascular Function in COPD Patients

NCT03055988

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2017-03-29

PhasePHASE4

Study timeline

Study start (actual)2017-03-29Date precision: day

Registry last updated2019-08-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Disease, Chronic Obstructiveunresolved

Interventions

TiotropiumDRUG · verified · RxNorm: tiotropium

OlodaterolDRUG · verified · RxNorm: olodaterol

Fluticasone propionateDRUG · verified · RxNorm: fluticasone propionate

SalmeterolDRUG · verified · RxNorm: salmeterol

Sponsors & collaborators

Boehringer Ingelheimlead sponsor

Mapped research locations

FrankfurtGermany2 BerlinGermany1 HeidelbergGermany1 MainzGermany1 BonnGermany1 LübeckGermany1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03055988 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.